News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Supreme Court Rejects Johnson & Johnson (JNJ)'s Lawsuit Over Abbott Laboratories (ABT)'s Humira


2/22/2012 6:54:28 AM

The U.S. Supreme Court on Tuesday refused to consider a Johnson & Johnson subsidiary's bid to save its high-stakes patent lawsuit targeting Abbott Laboratories' blockbuster treatment for rheumatoid arthritis. Last February, a federal appeals court threw out a 2009 jury verdict that ordered Abbott to pay $1.67 billion in damages because its arthritis therapy Humira allegedly infringed a patent co-owned by J&J unit Centocor Ortho Biotech, now known as Janssen Biotech, and New York University. The appeals court ruling, which removed a major legal cloud hanging over Abbott, said Centocor's patent claims were invalid because they lacked adequate written descriptions.

Read at Wall Street Journal
Read at CBS News
Read at News Release
Read at Reuters

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES